CMV Activators

ytomegalovirus (CMV) is a member of the Herpesviridae family, a group of viruses known for causing latent infections with reactivation. CMV is widespread in human populations and can infect a variety of cell types, including fibroblasts, epithelial cells, endothelial cells, and leukocytes.In healthy individuals, CMV infection usually remains asymptomatic or causes mild indications. However, it can be a significant cause of disease in newborns (congenital CMV) and immunocompromised individuals, such as transplant recipients, HIV/AIDS, or those receiving immunosuppressive therapy. In these populations, CMV can lead to severe complications, including retinitis, pneumonia, and gastrointestinal disease.

CMV has a large double-stranded DNA genome, encoding numerous proteins that facilitate its replication, evade the host immune response, and control the host cell environment. These include immediate-early, early, and late proteins, each group being expressed at different stages of the viral replication cycle. The immediate-early proteins are crucial for initiating the viral replication process and modulating host cell functions, early proteins are mainly involved in DNA replication and metabolism, and late proteins are structural components of the virus.The virus establishes latency primarily in myeloid lineage cells, and reactivation can occur under conditions of immune suppression or stress. CMV's ability to establish lifelong latency and periodically reactivate makes it a persistent challenge.